The FDA announced on Oct. 24, 2012, that GlaxoSmithKline LLC voluntarily recalled Advair HFA Inhalation Aerosol units due to stability failures. The agency said the lots failed to meet particle size distribution specifications.
How to tell if you have it
- Brand: GlaxoSmithKline
- Product: Advair HFA Inhalation Aerosol
- NDC: 0173-0715-20
- Lot codes: 1ZP2465, 1ZP5224, 1ZP5455, 1ZP6916, 1ZP8042, 1ZP9593, 1ZP9900, 1ZP1134, 1ZP3190, 2ZP6531, 2ZP6924, 2ZP7258, 2ZP1886, 2ZP9975, 2ZP0027, 2ZP9782, 2ZP1331, 2ZP2366
- Expiration dates: Oct-12, Nov-12, Dec-12, Jan-13, Mar-13, Apr-13, May-13, Jul-13, Sep-13, Oct-13, Nov-13
- Quantity: 310,964 Aerosol Units
The hazard
According to the FDA, the recalled lots failed to meet particle size distribution specifications. The agency classified this as a Class III recall.
Context
GovInfoNow's records show GlaxoSmithKline LLC has 11 other recalls on record since 2012-10-08. Other recent recalls of similar products include Tivicay PD Recall (2024-05-17), GlaxoSmithKline ANORO ELLIPTA inhaler recall (2023-12-12), and GlaxoSmithKline Tivicay Tablets (2022-05-13). Other recent recalls of similar products include Golden State Medical Recalls Prasugrel HCl 10mg Tablets (2026-08-21), Safecor Health Fluphenazine Elixir Recall (2026-08-13), and Ajanta Pharma Fenofibrate Capsules Recall (2026-05-28).